Neogen Chemicals Limited makes a corporate announcement

The preferential allotment created 3.65% dilution for existing shareholders on a post-issue basis. Neogen issued 10,00,000 new shares, increasing total shares from 2,63,81,674 to 2,73,81,674; the new shares represented 3.79% of the pre-issue capital and 3.65% of the post-issue capital. Thus, existing shareholders’ aggregate ownership declined from 100% to 96.35%, a relative dilution of 3.65%. Paid-up equity capital rose from ₹26.38 Cr to ₹27.38 Cr. ^[1]

Use of the ₹161 Cr preferential-issue proceeds

The company did not designate the preferential proceeds as a separate debt-repayment allocation in the original objects. The finalized deployment was:

• ₹100 Cr for battery-materials capex: invested in Neogen Ionics through CCDs and ultimately used for equipment, civil, fabrication and other capital expenditure at the Pakhajan project. ^[2]
• ₹61 Cr for cash-credit adjustment: the balance of the fully utilized ₹161 Cr was applied toward adjustment of the company’s cash-credit facility. ^[3] This is economically debt reduction, although the monitoring disclosure describes it as cash-credit adjustment rather than term-debt repayment.
• No unutilized balance remained as of June 30, 2026. ^[2]

On a derived basis, the ₹100 Cr capex allocation represented 62.1% of the preferential proceeds, while the ₹61 Cr cash-credit adjustment represented 37.9%. The ₹100 Cr was only a funding tranche for the Pakhajan project; the combined Dahej Phase 1 and Pakhajan Phase 2 battery-materials projects were subsequently estimated at ₹1,795 Cr. ^[4]

Important distinction: the explicit debt repayment/prepayment mandate relates to the later approximately ₹600 Cr QIP, not to the ₹161 Cr promoter preferential issue. ^[5]

On a consolidated basis, the fire incident involved:

• Insurance claim recognized: ₹348.82 Cr, against a gross fire loss of ₹362.90 Cr.
• Net exceptional item in the P&L: ₹14.08 Cr, representing the unrecovered portion of the loss at initial recognition. Both amounts were recorded in FY25, not as a new FY26 exceptional charge. ^[6]
• Outstanding insurance claim receivable as of March 31, 2026: ₹203.18 Cr. This reflects ₹140.00 Cr received from the insurer, ₹7.05 Cr realized from scrap, and ₹1.41 Cr of additional claimable expenses. ^[6]

Thus, the relevant receivable balance at March 31, 2026 was ₹203.18 Cr, with management stating that it was fully recoverable.

Neogen is adding 30,000 MT of electrolyte capacity and 5,100 MT of lithium electrolyte salts/additives capacity versus the FY25 base, against ₹1,795 Cr of planned battery-materials capex. That gives a mechanically blended capital intensity of approximately ₹5.1 lakh per incremental MT. However, a verified comparison with historical specialty-chemicals capex intensity is not possible because the company has not paired its earlier capacity additions with project-level capex.

Capacity and implied capital intensity

† Mechanical blended calculation across two different products; it is not a product-level economic cost comparison. ‡ Derived from FY27 planned capacity of 32,000 MT electrolytes and 5,500 MT salts/additives, less FY25 capacity of 2,000 MT and 400 MT respectively ^[8]. The ₹1,795 Cr program comprises ₹428 Cr for Dahej Phase 1 and ₹1,367 Cr for Pakhajan Phase 2 ^[7].

Comparison with historical specialty chemicals

The disclosed historical benchmark is the Patancheru specialty-chemicals expansion, where capacity increased from 120 MT per annum to 300 MT per annum, implying a 180 MT addition ^[7]. The associated project capex is not reported alongside that capacity figure, so a historical ₹/MT benchmark cannot be calculated.

Analyst read: the battery-materials program is much larger and more integrated than the cited Patancheru expansion, so the ₹5.1 lakh/MT figure should be treated only as a program-level screening metric. The comparison is further limited because electrolytes and lithium salts have different plant configurations, technology requirements and likely economics; the company has not disclosed capex allocation between the two product streams.